(b)(4).(b)(4) (importer) evaluated the device.It was found that the device energy output was below specifications.(b)(4) was recently made aware of an incident that "ocurred" in 2017 through a third-party.(b)(4) made multiple attempts to obtain information about the alleged incident from the facility, however, received no response.In "absense" of any information, (b)(4).Regulatory advised to perform another follow-up in case any additional details become available.On 11/01/2018, (b)(4) received additional information from a third party.After the review, (b)(4) clinical concluded that given the information pertaining to patient's skin condition even after 90 days, the event is to be reported in compliance with the company's protocol and in good faith.In the absence of pertinent clinical parameters and photographs, (b)(4) clinical cannot fully ascertain the root cause.
|